CUV 3.31% $13.73 clinuvel pharmaceuticals limited

THE CLINUVEL SHARE BUYBACK, page-28

  1. 776 Posts.
    lightbulb Created with Sketch. 223
    Agree. And hope the BB does re-commence post results. You could argue the current SP is reasonable if you afford it a relative low PE - If they maintain around 60c per share earnings, at 20 PE would value them around $12. Unsure re earnings but given the adolescent label has been delayed and no other material income outside EPP, similar earnings to last year would not surprise. A slightly higher Div won’t hurt. Of course adding in the pipeline changes everything but fair the market wants to see the money first. For recent investor’s, the last 3 years results wouldn’t be encouraging IMO. Hopefully they get some momentum back in the next 2 years. Finger’s crossed results are better. GLTA
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$13.73
Change
-0.470(3.31%)
Mkt cap ! $687.3M
Open High Low Value Volume
$14.00 $14.00 $13.69 $929.6K 67.35K

Buyers (Bids)

No. Vol. Price($)
1 2000 $13.73
 

Sellers (Offers)

Price($) Vol. No.
$13.74 169 1
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.